Cargando…

Outcomes of spontaneous subarachnoid hemorrhage (sah) in neurocritical care unit: a multicenter study

Detalles Bibliográficos
Autores principales:	Iglesias Posadilla, D, Gero Escapa, M, González Robledo, J, Domínguez Berrot, A, González Salamanca, A, Nogales Martín, L, Montero Baladía, M, Diego Calvo, A, Riesco Crespo, M, Olmos Linares, AM, Bueno Sacristán, A, Ranedo Zaldo, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796101/ http://dx.doi.org/10.1186/2197-425X-3-S1-A773

Ejemplares similares

Short-term outcomes after repair treatment (clipping or coiling) in aneurysmal subarachnoid hemorrhage (ASAH): a prospective multicenter study
por: Gero Escapa, M, et al.
Publicado: (2015)

Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
por: Schneider, U.C., et al.
Publicado: (2018)

Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021)

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
por: Rhim, Ha-Young, et al.
Publicado: (2021)

Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Ran, Kathleen R, et al.
Publicado: (2023)

Initial severity of aneurysmal subarachnoid hemorrhage (SAH): Trend over time
por: Sung, Seung Bin, et al.
Publicado: (2022)

Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2021)

Neurocritical care complications and interventions influence the outcome in aneurysmal subarachnoid hemorrhage
por: Hammer, Alexander, et al.
Publicado: (2021)

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
por: Rivero-Arias, Oliver, et al.
Publicado: (2010)

Follow-up of Vasospasm by Transcranial Doppler Sonography (TCD) in Subarachnoid Hemorrhage (SAH)
por: Djelilovic-Vranic, Jasminka, et al.
Publicado: (2017)

Exome sequencing study revealed novel susceptibility loci in subarachnoid hemorrhage (SAH)
por: Hao, Xiwa, et al.
Publicado: (2020)

Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
por: Arati, S., et al.
Publicado: (2019)

First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
por: Lilla, Nadine, et al.
Publicado: (2017)

Janus Faced HMGB1 and Post-Aneurysmal Subarachnoid Hemorrhage (aSAH) Inflammation
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2022)

Clustering of serum biomarkers involved in post-aneurysmal subarachnoid hemorrhage (aSAH) complications
por: Fischer, Igor, et al.
Publicado: (2023)

Effect of weekend admission on in-hospital mortality and functional outcomes for patients with acute subarachnoid haemorrhage (SAH)
por: Deshmukh, Harshal, et al.
Publicado: (2016)

Aneurysmal subarachnoid haemorrhage (aSAH): Five consecutive years' experience of Fars province, Iran
por: Rahmanian, Abdolkarim, et al.
Publicado: (2017)

Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2018)

Intracranial Venous Alteration in Patients With Aneurysmal Subarachnoid Hemorrhage: Protocol for the Prospective and Observational SAH Multicenter Study (SMS)
por: Umana, Giuseppe E., et al.
Publicado: (2022)

Monitoring of hypervolemic hemodilution and hypertensive (HHH) therapy in subarachnoid hemorrhage (SAH) patients with pulmonary artery catheter (PAC)
por: Nates, JL, et al.
Publicado: (1998)

Magnesium Levels and Diastolic Blood Pressure (DBP) as a Vasospasm Prediction Metric in Patients With Aneurysmal Subarachnoid Hemorrhage (SAH)
por: Savla, Paras, et al.
Publicado: (2022)

Neurocritical Care Resource Utilization in Pandemics: A Statement by the Neurocritical Care Society
por: Moheet, Asma M., et al.
Publicado: (2020)

Development of a patient-reported outcome measure for patients who have recovered from a subarachnoid hemorrhage: the “questionnaire for the screening of symptoms in aneurysmal subarachnoid hemorrhage” (SOS-SAH)
por: Nobels-Janssen, Edith, et al.
Publicado: (2021)

Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (2000)

Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)
por: Heinz, Rebecca, et al.
Publicado: (2021)

The Prognostic Value of Neuropsychological Examination after SAH
por: Penninx, J. F., et al.
Publicado: (2010)

Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society
por: Wartenberg, Katja E., et al.
Publicado: (2019)

The structure of the SAM/SAH-binding riboswitch
por: Weickhmann, A Katharina, et al.
Publicado: (2019)

Should endovascular therapy for cerebral vasospasm coincide with hypervolemic-hypertensive therapy (HT) in aneurysmal subarachnoid hemorrhage (SAH)?
por: Liopyris, P, et al.
Publicado: (1999)

Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2017)

TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies
por: Heinz, Rebecca, et al.
Publicado: (2022)

Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies
por: Jin, Jing, et al.
Publicado: (2022)

Predisposing factors, neurological complications and sequels of guillain barre syndrome at discharge: experience in an ICU of a third level hospital
por: Portugal Rodríguez, E, et al.
Publicado: (2015)

Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2020)

The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Context of Aneurysmal Subarachnoid Hemorrhage (aSAH)—A Prospective Observational Study
por: Schmidt, Tobias P., et al.
Publicado: (2022)

Updates in Neurocritical Care
por: Lazaridis, Christos, et al.
Publicado: (2018)

Immunosenescence in neurocritical care
por: Inoue, Shigeaki, et al.
Publicado: (2018)

Neurocritical care update
por: Kuroda, Yasuhiro
Publicado: (2016)

Multimodal neurocritical monitoring
por: Yang, Ming-Tao
Publicado: (2020)

Neurocritical Care and Neurotrauma
por: Ha, Eun Jin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_urhbnaqdupgf2fdg4s999cij95